These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28008855)

  • 21. Re: Jim C. Hu, David M. Nanus, Art Sedrakyan. Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States. Eur Urol 2017;71:147-9.
    Kim JH; Khandwala YS; Chung BI
    Eur Urol; 2017 Aug; 72(2):e41-e42. PubMed ID: 28365161
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Rano Matta, Christopher J.D. Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3-7: Translational Potential of Dual Detection: Depression Diagnosis plus Sense of Coherence Determination in Prostate Cancer.
    Vale S
    Eur Urol; 2019 Jun; 75(6):e168-e169. PubMed ID: 30732926
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82: Looking Deeper: P-hacking and Some Other Bias.
    García-Perdomo HA; Manzano Nunez R
    Eur Urol; 2016 Dec; 70(6):e155. PubMed ID: 27156130
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019;75:558-61.
    Heidegger I; Pichler R
    Eur Urol; 2019 Jun; 75(6):e158-e159. PubMed ID: 30616947
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol 2022;82:341-51.
    Sirufo MM; Ginaldi L; De Martinis M
    Eur Urol; 2023 Apr; 83(4):e102. PubMed ID: 36670032
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Elizabeth J. Schafer, Ahmedin Jemal, Daniel Wiese, et al. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA. Eur Urol. 2023;84:117-26.
    Hsiao PR; Sung WW
    Eur Urol; 2023 Oct; 84(4):e92. PubMed ID: 37482514
    [No Abstract]   [Full Text] [Related]  

  • 27. Trends in prostate cancer. 1980-1988.
    Wkly Epidemiol Rec; 1992 Sep; 67(38):281-4. PubMed ID: 1390043
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
    von Eyben FE; Virgolini I; Roviello G
    Eur Urol; 2018 Feb; 73(2):e31. PubMed ID: 28869068
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Scott D. Lundy, Naseer Sangwan, Neel V. Parekh, et al. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur Urol 2021;79:826-36.
    Ventimiglia E; Pozzi E; Alfano M; Montorsi F; Salonia A
    Eur Urol; 2021 Aug; 80(2):e53-e54. PubMed ID: 34024650
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66.
    Hemminki K; Ji J; Sundquist J
    Eur Urol; 2023 Jul; 84(1):e13-e14. PubMed ID: 37061447
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Monique J. Roobol, Ewout W. Steyerberg, Ries Kranse, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010;57:79-85.
    Morrod D
    Eur Urol; 2010 Sep; 58(3):327; author reply 328-30. PubMed ID: 20598799
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for
    Lopci E; Chiti A; Lazzeri M
    Eur Urol; 2016 Oct; 70(4):e112-e113. PubMed ID: 27021795
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12.
    Fankhauser CD; Mucci LA; Gerke TA
    Eur Urol; 2017 Jul; 72(1):e9-e10. PubMed ID: 28108146
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12.
    Yuan R
    Eur Urol; 2018 Dec; 74(6):e149-e150. PubMed ID: 30177284
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83.
    Fanti S; Krause B; Weber W; Castellucci P; Grosu AL; de Jong IJ; Messa C; Picchio M; Pruim J; Langsteger W; Chiti A;
    Eur Urol; 2011 Nov; 60(5):e37-8; author reply e39-41. PubMed ID: 21855205
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur urol 2012;62:745-52.
    Braillon A; Dubois G
    Eur Urol; 2012 Nov; 62(5):e89; author reply e90-1. PubMed ID: 22858456
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65.
    Froehner M; Koch R; Wirth MP
    Eur Urol; 2016 Jun; 69(6):e128. PubMed ID: 26456682
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110.
    Stattin P; Robinson D; Lambe M
    Eur Urol; 2015 Nov; 68(5):e110. PubMed ID: 26184974
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
    Boscolo-Berto R; Galfano A; Iafrate M
    Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to Cédric Annweiler, Pierre Bigot, and Spyridon N. Karras' Letter to the Editor re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82.
    Rider JR; Wilson KM; Mucci LA; Giovannucci EL
    Eur Urol; 2017 Jan; 71(1):e18. PubMed ID: 27317088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.